Therefore, we analyzed whether ATX or M2BPGi was a higher predictive capacity for post-SVR HCC development, and we revealed that M2BPGi was a more useful marker than ATX (Table 1). The gene discussed is ENPP2; the disease is hepatocellular carcinoma.